Results 31 to 40 of about 377,194 (138)

Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study. [PDF]

, 2015
BACKGROUND: Spiromax® is a novel dry-powder inhaler containing formulations of budesonide plus formoterol (BF). The device is intended to provide dose equivalence with enhanced user-friendliness compared to BF Turbuhaler® in asthma and chronic ...
Philip Chetcuti, Hosker, Harold, Chrystyn, Henry, Azouz, Wahida, Saralaya, Dinesh, Dinesh Saralaya, Chetcuti, Philip, Wahida Azouz, Henry Chrystyn, Harold Hosker   +9 more
core   +1 more source

Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists

Heliyon, 2023
Toll-like receptor (TLR) agonists are recognized as potential immune-enhancing adjuvants and are included in several licensed vaccines. Monophosphoryl lipid A (MPL®, GlaxoSmithKline) is one such TLR4 agonist that has been approved for use in human ...
Gang Hu, David J. Varisco, Sayan Das, C. Russell Middaugh, Francesca Gardner, Robert K. Ernst, Wendy L. Picking, William D. Picking   +7 more
doaj   +1 more source

Extracting positive descriptions and exploring landscape value using text analysis in the Cairngorms National Park [PDF]

, 2023
<p>The dataset was retrieved August 31, 2023, from <a href="http://data.geograph.org.uk/dumps/">http://data.geograph.org.uk/dumps/</a></p><p>Geograph project require all submitters to adopt a Creative Commons Attribution ...
Geograph® Britain and Ireland project
core   +1 more source

Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes. [PDF]

, 2014
Aim of this investigator-initiated study was to evaluate and compare the titres of neutralizing and cross-neutralizing antibodies (NAbs) induced by the bivalent (Cervarix(®)) and quadrivalent (Gardasil(®)) HPV vaccines in a cohort of girls aged 11-13 ...
Squarzon, Laura, Squarzon L, PALU', GIORGIO, Pascucci, Maria Grazia, Gabrielli, Liliana, Pacenti M, Lazzarotto T, BARZON, LUISA, Gabrielli L, Pacenti, Monia, Masiero S, Palù, Giorgio, Pascucci MG, Marcati G, CAPUTO, ANTONELLA, Marcati, Giorgia, MANTELLI, BARBARA, Masiero, Serena, LAZZAROTTO, TIZIANA   +18 more
core   +1 more source

Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada

The International Journal of Health Planning and Management, Volume 41, Issue 4, Page 572-579, July 2026.
ABSTRACT Introduction This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi‐ethnic group of youth (aged 11–23 years) in Edmonton, Alberta, Canada. Method Using a cross‐sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire.
Sarah Deck, Se Lim Jang, Rachel Harris, Fariba Kolahdooz, Moutasem Zakkar, Sangita Sharma   +5 more
wiley   +1 more source

Human papillomavirus: Role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa

International Journal of Infectious Diseases
Cervical cancer remains a leading cause of death among women in sub-Saharan Africa, accounting for nearly a quarter of global deaths from this disease. Its high incidence is due to the high prevalence of HIV, the persistence of human papillomavirus (HPV)
Christian Tague, Ayesha Junaid, Yousra Anwar, Sarah Asad, Dhruv Gehlot, Afsheen Azhar, Zainab Abdul Hamid, Simran Parkash, Johan Armel Domga Kaptso, Germain Cebweru Murhola, Criss Koba Mjumbe   +10 more
doaj   +1 more source

Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9

Human Vaccines & Immunotherapeutics, 2019
High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic vaccines available that protect against the majority of HPVs associated with cancer.
Nitesh K. Kunda, Julianne Peabody, Lukai Zhai, Dominique N. Price, Bryce Chackerian, Ebenezer Tumban, Pavan Muttil   +6 more
doaj   +1 more source

Human Papillomavirus: Update in Bridging Basic Science to Clinical and Public Health Innovations

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Human papillomavirus (HPV), a non‐enveloped, double‐strand DNA viral pathogen, is intricately linked with the onset of various cancers, including cervical cancer and head and neck cancers. The present paper delves into HPV's ancient recognition and significant milestones such as the discovery of its role in oncogenesis and the development of ...
Fatemeh Beygnejad, Narges Eslami, Kaveh Gharaei Nejad, Atefeh Zamani Kermanshahi, Hossein Bannazadeh Baghi   +4 more
wiley   +1 more source

Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Oncogenic viral and bacterial infections constitute a significant portion of the global cancer burden, accounting for up to 15% of cases, particularly in low‐ and middle‐income countries. Prophylactic vaccination thus appears to be the most effective tool for preventing these preventable cancers, especially those linked to human papillomavirus
Christian Tague, Johan Domga, Ayesha Junaid, Okhesomi Rejoice Eshemokhai, Josias Kamgang Silatchom, Criss Koba Mjumbe   +5 more
wiley   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç« [PDF]

, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質èå¹æ ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼åå競ç­çç°å¢ï¼é²èé æ業èé競ç­åå¹å½±é¿å¶å質èå©æ½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core